Amgen Buy or Sell Recommendation

Macroaxis provides Amgen Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Amgen positions. The advice algorithm takes into account all of Amgen Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Amgen buy-and-hold prospective. Check also Amgen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
Amgen Inc -- USA Stock  

USD 183.55  0.05  0.0272%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Amgen Inc is 'Strong Hold'.
For the selected time horizon Amgen Inc has a risk adjusted performance of 0.06075, jensen alpha of 0.0314, total risk alpha of 0.0823, sortino ratio of 0.0 and treynor ratio of 0.10
Macroaxis provides buy, hold, or sell suggestion on Amgen Inc to complement and cross-verify current analyst consensus on Amgen Inc. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Amgen is not overpriced, please confirm all Amgen Inc fundamentals including its EBITDA, Cash Flow from Operations and the relationship between Price to Book and Total Debt . Given that Amgen Inc has Price to Earning of 68.23 times, we suggest you validate Amgen Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.08Value At Risk3.4
Potential Upside2.27Standard Deviation2.11
 Return Density 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares52.3 M9.1 B
Fmr LlcCommon Shares51.9 M9 B
Capital Research Global InvestorsCommon Shares50.9 M8.9 B
Blackrock IncCommon Shares49.4 M8.6 B
State Street CorpCommon Shares31.6 M5.5 B
Primecap Management CoCommon Shares22 M3.8 B
Northern Trust CorpCommon Shares9.8 M1.7 B

Amgen Greeks

Alpha over DOW
Beta against DOW=0.86
Overall volatility
Information ratio =0.0238

Amgen Volatility Alert

Amgen Inc exhibits very low volatility with skewness of -1.45 and kurtosis of 2.92. However, we advise investors to further study Amgen Inc technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Amgen to competition
FundamentalsAmgenPeer Average
Return On Equity7.18 % (15.17) %
Return On Asset8.32 % (15.64) %
Profit Margin8.66 % (5.50) %
Operating Margin54.45 % (10.91) %
Current Valuation125.92 B152.14 B
Shares Outstanding720.56 M1.43 B
Shares Owned by Insiders0.15 % 6.91 %
Shares Owned by Institutions82.24 % 18.37 %
Number of Shares Shorted8.03 M3.24 M
Price to Earning68.23 times40.69 times
Price to Book5.25 times14.44 times
Price to Sales5.79 times17.81 times
Revenue22.85 B9.85 B
Gross Profit18.78 B21.75 B
EBITDA12.44 B1.41 B
Net Income1.98 B517.71 M
Cash and Equivalents41.68 B3.89 B
Cash per Share57.84 times5.17 times
Total Debt35.34 B7.36 B
Debt to Equity140.00 % 0.72 %
Current Ratio5.49 times3.30 times
Book Value Per Share34.95 times13.64 times
Cash Flow from Operations8.55 B1.25 B
Short Ratio2.71 times2.09 times
Earnings Per Share2.69 times2.30 times
Price to Earnings To Growth3.24 times1.22 times
Number of Employees20.8 K10.67 K
Market Capitalization132.26 B29.78 B
Total Asset71.58 B126.86 B
Retained Earnings(438 M)38.24 B
Working Capital29.85 B3.58 B
Current Asset38.52 B36.8 B
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Acquisition by Stuart Tross of 8324 shares of Amgen subject to Rule 16b-3 [view details]
Risk Adjusted Performance0.06075
Market Risk Adjusted Performance0.091047
Mean Deviation1.44
Coefficient Of Variation2,724
Standard Deviation2.11
Information Ratio0.0238
Jensen Alpha0.0314
Total Risk Alpha0.0823
Treynor Ratio0.10
Maximum Drawdown9.54
Value At Risk3.40
Potential Upside2.27

Current Valuation

Amgen Current Valuation Analysis
Amgen Inc is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceuticals And Biosciences industry is presently estimated at about 372.53 Billion. Amgen totals roughly 125.92 Billion in current valuation claiming about 34% of equities listed under Pharmaceuticals And Biosciences industry.